Vertex Pharmaceuticals Incorporated ( VRTX) was a big mover last session, as the company saw its shares catapult over a whopping 40% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the flattish price range of $66.61 to $74.61 in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate of a loss has narrowed, suggesting that more solid trading could be ahead for Vertex. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Vertex Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked players in the healthcare industry include Illumina Inc. ( ILMN ), Gilead Sciences Inc. ( GILD ) and ANI Pharmaceuticals, Inc. ( ANIP ) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
VERTEX PHARM (VRTX): Free Stock Analysis Report
ILLUMINA INC (ILMN): Free Stock Analysis Report
GILEAD SCIENCES (GILD): Free Stock Analysis Report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research